← Leaderboards
Thomas A Buchanan
University Of Southern California
$121,360,154
Attributed
$158,877,632
Total exposure
43
Grants
32
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $23.8M · FY2005–25$25M$18.8M$12.5M$6.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$180,269,619 · 45
By mechanism
UL1$150,437,812 · 12
R01$12,542,971 · 2
M01$8,427,889 · 24
U01$3,860,353 · 1
KL2$3,693,992 · 2
TL1$817,602 · 2
Top collaborators
- Michele D Kipke12 shared
- Anny H Xiang4 shared
Most similar at University Of Southern California
Same institution · by research overlap
- Donna D Spruijt-Metz$9,282,949
- Cecilia Maria Patino Sutton$2,897,920
- Jaimie Nicole Davis$4,966,715
- Richard M Watanabe$9,279,898
- Shohreh F Farzan$12,349,678
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchResearch PersonnelInsulin Sensitivity /ResistanceResourcesHuman SubjectHispanic AmericansTranslational ResearchLos AngelesGestational Diabetes MellitusNoninsulin Dependent Diabetes MellitusNovel StrategiesClinical SciencesInstitutesFemaleBaseCommunitiesTrainingVisionHealth OrganizationCommunity HealthResearch InfrastructureEnvironmentPopulation HeterogeneityPrograms
Grant awards (116)
Southern California Clinical and Translational Science Institute$9,143,711
UL1 · FY2025 · TR · contact PI
Southern California Clinical and Translational Science Institute$9,192,884
UL1 · FY2024 · TR · contact PI
Southern California Clinical and Translational Science Institute$9,192,884
UL1 · FY2023 · TR · contact PI
Southern California Clinical and Translational Science Institute$49,860
UL1 · FY2023 · TR · contact PI
Southern California Clinical and Translational Science Institute$9,009,695
UL1 · FY2022 · TR · contact PI
Southern California Clinical and Translational Science Institute$2,832,887
UL1 · FY2021 · TR · contact PI
Southern California Clinical and Translational Institute$4,367,172
UL1 · FY2020 · TR · contact PI
Southern California Clinical and Translational Institute$4,367,195
UL1 · FY2019 · TR · contact PI
Southern California Clinical and Translational Institute$534,703
UL1 · FY2019 · TR · contact PI
Southern California Clinical and Translational Institute$6,091,162
UL1 · FY2018 · TR · contact PI
Southern California Clinical and Translational Institute$7,816,751
UL1 · FY2017 · TR · contact PI
Southern California Clinical and Translational Institute$9,557,480
UL1 · FY2016 · TR · contact PI
Southern California Clinical and Translational Science Institute$5,487,865
UL1 · FY2015 · TR · contact PI
Beta Cell Restoration through Fat Mitigation$944,228
U01 · FY2015 · DK · contact PI
Beta Cell Restoration through Fat Mitigation$275,063
U01 · FY2015 · DK · contact PI
Southern California Clinical and Translational Science Institute$169,031
KL2 · FY2015 · TR · contact PI
Southern California Clinical and Translational Science Institute$10,288,421
UL1 · FY2014 · TR · contact PI
Beta Cell Restoration through Fat Mitigation$645,762
U01 · FY2014 · DK · contact PI
Southern California Clinical and Translational Science Institute$582,641
KL2 · FY2014 · TR · contact PI
Southern California Clinical and Translational Science Institute$158,737
TL1 · FY2014 · TR · contact PI
Southern California Clinical and Translational Science Institute$123,041
UL1 · FY2014 · TR · contact PI
Southern California Clinical and Translational Science Institute$9,465,437
UL1 · FY2013 · TR · contact PI
Southern California Clinical and Translational Science Institute$805,680
KL2 · FY2013 · TR · contact PI
Beta Cell Restoration through Fat Mitigation$645,762
U01 · FY2013 · DK · contact PI
Southern California Clinical and Translational Science Institute$166,103
TL1 · FY2013 · TR · contact PI
Los Angeles Basin Clinical and Translational Science Institute$10,621,690
UL1 · FY2012 · TR · contact PI
Beta Cell Restoration through Fat Mitigation$665,564
U01 · FY2012 · DK · contact PI
Genetics of Beta Cell Failure in Mexican Americans$652,215
R01 · FY2012 · DK · contact PI
Los Angeles Basin Clinical and Translational Science Institute$525,280
KL2 · FY2012 · TR · contact PI
Los Angeles Basin Clinical and Translational Science Institute$166,103
TL1 · FY2012 · TR · contact PI
Los Angeles Basin Clinical and Translational Science Institute$10,288,417
UL1 · FY2011 · RR · contact PI
LOS ANGELES BASIN CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE$6,622,803
UL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$1,528,414
UL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$1,528,414
UL1 · FY2011 · RR · contact PI
Los Angeles Basin Clinical and Translational Science Institute$805,680
KL2 · FY2011 · RR · contact PI
Beta Cell Restoration through Fat Mitigation$683,974
U01 · FY2011 · DK · contact PI
Genetics of Beta Cell Failure in Mexican Americans$676,315
R01 · FY2011 · DK · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$537,758
UL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$537,757
UL1 · FY2011 · RR · contact PI
Los Angeles Basin Clinical and Translational Science Institute$291,730
UL1 · FY2011 · RR · contact PI
Los Angeles Basin Clinical and Translational Science Institute$174,999
UL1 · FY2011 · RR · contact PI
Los Angeles Basin Clinical and Translational Science Institute$164,237
TL1 · FY2011 · RR · contact PI
Los Angeles Basin Clinical and Translational Science Institute$10,392,341
UL1 · FY2010 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$7,794,256
UL1 · FY2010 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$2,390,238
UL1 · FY2010 · RR · contact PI
Los Angeles Basin Clinical and Translational Science Institute$805,680
KL2 · FY2010 · RR · contact PI
Genetics of Beta Cell Failure in Mexican Americans$774,464
R01 · FY2010 · DK · contact PI
Los Angeles Basin Clinical and Translational Science Institute$162,422
TL1 · FY2010 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$103,924
UL1 · FY2010 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$103,923
UL1 · FY2010 · RR · contact PI
Genetics of Beta Cell Failure in Mexican Americans$775,579
R01 · FY2009 · DK · contact PI
ACT NOW STUDY: ACTOS NOW FOR THE PREVENTION OF DIABETES$296,827
M01 · FY2009 · RR · contact PI
PANCREATIC B-CELL FUNCTION IN SIBLINGS OF WOMEN WITH GESTATIONAL DIABETES$128,703
M01 · FY2009 · RR · contact PI
GENETICS OF BETA CELL FAILURE IN MEXICAN AMERICANS - PHASE II$11,594
M01 · FY2009 · RR · contact PI
PANCREATIC B-CELL FUNCTION IN SIBLINGS OF WOMEN WITH GESTATIONAL DIABETES$1,126,026
M01 · FY2008 · RR · contact PI
ACT NOW STUDY: ACTOS NOW FOR THE PREVENTION OF DIABETES$384,557
M01 · FY2008 · RR · contact PI
PATHOGENESIS OF NON-INSULIN DEPENDENT DIABETES MELLITUS$48,068
M01 · FY2008 · RR · contact PI
Genetics of Beta Cell Failure in Mexican Americans$1,325,787
R01 · FY2007 · DK · contact PI
PANCREATIC B-CELL FUNCTION IN SIBLINGS OF WOMEN WITH GESTATIONAL DIABETES$908,058
M01 · FY2007 · RR · contact PI
ACT NOW STUDY: ACTOS NOW FOR THE PREVENTION OF DIABETES$310,117
M01 · FY2007 · RR · contact PI
PATHOGENESIS OF NON-INSULIN DEPENDENT DIABETES MELLITUS$38,764
M01 · FY2007 · RR · contact PI
Genetics of Beta Cell Failure in Mexican Americans$1,368,652
R01 · FY2006 · DK · contact PI
PANCREATIC B-CELL FUNCTION IN SIBLINGS OF WOMEN WITH GESTATIONAL DIABETES$752,301
M01 · FY2006 · RR · contact PI
ACT NOW STUDY: ACTOS NOW FOR THE PREVENTION OF DIABETES$604,223
M01 · FY2006 · RR · contact PI
Pathogenesis of Type 2 Diabetes in Latino Women$318,258
R01 · FY2006 · DK · contact PI
Planning Grant for Institutional Clinical and Translational Science Award$244,500
P20 · FY2006 · RR · contact PI
PLANNING GRANT FOR INSTITUTIONAL CLINICAL AND TRANSLATIONAL SCIENCE AWARD$244,500
P20 · FY2006 · RR · contact PI
PATHOGENESIS OF NON-INSULIN DEPENDENT DIABETES MELLITUS$63,143
M01 · FY2006 · RR · contact PI
PIOGLITAZONE IN WOMEN WITH PRIOR GESTATIONAL DIABETES$13,064
M01 · FY2006 · RR · contact PI
Genetics of Beta Cell Failure in Mexican Americans$1,362,609
R01 · FY2005 · DK
PANCREATIC B-CELL FUNCTION IN SIBLINGS OF WOMEN WITH GESTATIONAL DIABETES$749,316
M01 · FY2005 · RR
Pathogenesis of Type 2 Diabetes in Latino Women$325,000
R01 · FY2005 · DK
PIOGLITAZONE IN WOMEN WITH PRIOR GESTATIONAL DIABETES$308,856
M01 · FY2005 · RR
ACT NOW STUDY: ACTOS NOW FOR THE PREVENTION OF DIABETES$277,867
M01 · FY2005 · RR
PATHOGENESIS OF NON-INSULIN DEPENDENT DIABETES MELLITUS$57,847
M01 · FY2005 · RR
Genetics of Beta Cell Failure in Mexican Americans$1,379,331
R01 · FY2004 · DK
Pancreatic B-cell Function in Siblings of Women GDM$741,353
M01 · FY2004 · RR
Pioglitazone in Women with Prior Gestational Diabetes$428,980
M01 · FY2004 · RR
Pathogenesis of Type 2 Diabetes in Latino Women$325,000
R01 · FY2004 · DK
Pathogenesis of Non-Insulin Dependent Diabetes Mellitus$34,234
M01 · FY2004 · RR
Genetics of Beta Cell Failure in Mexican Americans$1,386,429
R01 · FY2003 · DK
Genetics of Beta Cell Failure in Mexican Americans$275,222
R01 · FY2003 · DK
PATHOGENESIS OF TYPE 2 DIABETES IN LATINO WOMEN$381,329
R01 · FY2002 · DK
TRIAL OF TROGLITAZONE IN WOMEN WI PRIOR GESTATIONAL DIABETES MELLITUS$190,747
M01 · FY2002 · RR
TROGLITAZONE IN WOMEN WITH PRIOR GESTATIONAL DIABETES MELLITUS$0
M01 · FY2002 · RR
GENETIC RELATIONSHIPS BETWEEN NIDDM AND ATHEROSCLEROSIS IN HISPANICS$0
M01 · FY2002 · RR
EFFECT OF MAGNESIUM SUPPLEMENTATION ON CARBOHYDRATE METABOLISM$0
M01 · FY2002 · RR
MOLECULAR GENETICS OF HYPERTENSION (HYPERTENSION SCOR)$0
M01 · FY2002 · RR
PATHOGENESIS OF NONINSULIN DEPENDENT DIABETES MELLITUS$0
M01 · FY2002 · RR
PATHOGENESIS OF TYPE 2 DIABETES IN LATINO WOMEN$421,732
R01 · FY2001 · DK
PATHOGENESIS OF NONINSULIN DEPENDENT DIABETES MELLITUS$155,764
M01 · FY2001 · RR
GENETIC RELATIONSHIPS BETWEEN NIDDM AND ATHEROSCLEROSIS IN HISPANICS$155,764
M01 · FY2001 · RR
EFFECT OF MAGNESIUM SUPPLEMENTATION ON CARBOHYDRATE METABOLISM$155,764
M01 · FY2001 · RR
MOLECULAR GENETICS OF HYPERTENSION (HYPERTENSION SCOR)$155,764
M01 · FY2001 · RR
TROGLITAZONE IN WOMEN WITH PRIOR GESTATIONAL DIABETES MELLITUS$155,764
M01 · FY2001 · RR
PATHOGENESIS OF NONINSULIN DEPENDENT DIABETES MELLITUS$0
M01 · FY2001 · RR
TROGLITAZONE IN WOMEN WITH PRIOR GESTATIONAL DIABETES MELLITUS$0
M01 · FY2001 · RR
TRIAL OF TROGLITAZONE IN WOMEN WI PRIOR GESTATIONAL DIABETES MELLITUS$0
M01 · FY2001 · RR
GENETIC RELATIONSHIPS BETWEEN NIDDM AND ATHEROSCLEROSIS IN HISPANICS$0
M01 · FY2001 · RR
MOLECULAR GENETICS OF HYPERTENSION (HYPERTENSION SCOR)$0
M01 · FY2001 · RR
EFFECT OF MAGNESIUM SUPPLEMENTATION ON CARBOHYDRATE METABOLISM$0
M01 · FY2001 · RR
PATHOGENESIS OF TYPE 2 DIABETES IN LATINO WOMEN$431,549
R01 · FY2000 · DK
PATHOGENESIS OF TYPE 2 DIABETES IN LATINO WOMEN$200,000
R01 · FY2000 · DK
PATHOGENESIS OF TYPE 2 DIABETES IN LATINO WOMEN$163,500
R01 · FY2000 · DK
PATHOGENESIS OF NONINSULIN DEPENDENT DIABETES MELLITUS$35,553
M01 · FY2000 · RR
GENETIC RELATIONSHIPS BETWEEN NIDDM AND ATHEROSCLEROSIS IN HISPANICS$35,553
M01 · FY2000 · RR
MOLECULAR GENETICS OF HYPERTENSION (HYPERTENSION SCOR)$35,553
M01 · FY2000 · RR
TROGLITAZONE IN WOMEN WITH PRIOR GESTATIONAL DIABETES MELLITUS$35,553
M01 · FY2000 · RR
TRIAL OF TROGLITAZONE IN WOMEN WI PRIOR GESTATIONAL DIABETES MELLITUS$32,212
M01 · FY2000 · RR
GENETIC RELATIONSHIPS BETWEEN NIDDM AND ATHEROSCLEROSIS IN HISPANICS$0
M01 · FY2000 · RR
PATHOGENESIS OF NONINSULIN DEPENDENT DIABETES MELLITUS$0
M01 · FY2000 · RR
TROGLITAZONE IN WOMEN WITH PRIOR GESTATIONAL DIABETES MELLITUS$0
M01 · FY2000 · RR
MOLECULAR GENETICS OF HYPERTENSION (HYPERTENSION SCOR)$0
M01 · FY2000 · RR
TRIAL OF TROGLITAZONE IN WOMEN WI PRIOR GESTATIONAL DIABETES MELLITUS$0
M01 · FY2000 · RR
PANCREATIC B-CELL FUNCTION IN SIBLINGS OF WOMEN W GESTATIONAL DIABETES$0
M01 · FY2000 · RR
PANCREATIC B-CELL FUNCTION IN SIBLINGS OF WOMEN W GESTATIONAL DIABETES$0
M01 · FY2000 · RR